We are live on ! Find out more
MESO

Mesoblast

26 hedge funds and large institutions have $13.3M invested in Mesoblast in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

13% more funds holding

Funds holding: 2326 (+3)

0% less ownership

Funds ownership: 0.26%0.26% (-0%)

2% less capital invested

Capital invested by funds: $13.6M → $13.3M (-$300K)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $82K

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
5
Reduced
7
Closed
2
Calls
Puts
$82K
Net Calls
-$82K
Net Calls Change
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
Toronto Dominion Bank
26
Toronto Dominion Bank
Ontario, Canada
+$317 +30 New
Simplex Trading
27
Simplex Trading
Illinois
+$412 +39 New

MESO Hedge Fund Activity: Q2 2019 in Review

26 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Mesoblast (MESO) for Q2 2019, worth a combined $13.3M — down 2.2% from $13.6M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new MESO positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $577K. The largest seller was Deutsche Bank, cutting an estimated $237K.

  • 26 institutional investors held Mesoblast (MESO) as of Q2 2019, up from 23 in Q1 2019.
  • Funds reported $13.3M of Mesoblast stock for Q2 2019, down 2.2% quarter-over-quarter.
  • 5 funds opened new Mesoblast positions in Q2 2019 and 2 closed out, a net change of +3 holders.
  • The largest Mesoblast buyer in Q2 2019 was Morgan Stanley, an estimated $577K added.
  • The largest Mesoblast seller in Q2 2019 was Deutsche Bank, an estimated $237K sold.

Based on aggregated 13F filings for Q2 2019.